Alpelisib (Standard) is the analytical standard of Alpelisib. This product is intended for research and analytical applications. Alpelisib (BYL-719) is a potent, selective, and orally active PI3Kalpha inhibitor. Alpelisib (BYL-719) shows efficacy in targeting PIK3CA-mutated cancer. Alpelisib (BYL-719) also inhibits p110alpha/p110gamma/p110delta/p110beta with IC50s of 5/250/290/1200 nM, respectively. Antineoplastic activity[1][2][3].
Molecular Weight:
441.47
Purity:
99.86
CAS Number:
[1217486-61-7]
Formula:
C19H22F3N5O2S
Target:
PI3K,Reference Standards
Application Notes:
MCE Product type: Reference Standards
* VAT and and shipping costs not included. Errors and price changes excepted
